High fibrinogen, thrombosis, cardiovascular diseases and overproduction of collagen

By SWA

Can high fibrinogen lead to sarcodosis or scleroderma?

High fibrinogen levels are primarily associated with an increased risk of thrombosis and cardiovascular diseases rather than directly causing conditions like sarcoidosis or scleroderma. However, the relationship between fibrinogen and these diseases can be considered from the perspective of inflammation and immune system dysregulation, which play roles in both sarcoidosis and scleroderma.

Sarcoidosis

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas, clusters of inflammatory cells, in various organs. The exact cause of sarcoidosis is unknown, but it's thought to involve an abnormal immune response. While high fibrinogen levels are a marker of inflammation and could theoretically be elevated in any inflammatory condition, including sarcoidosis, there's no direct evidence to suggest that high fibrinogen levels lead to sarcoidosis.

Scleroderma

Scleroderma, or systemic sclerosis, is a group of autoimmune diseases that cause the skin and connective tissues to harden and tighten. Like sarcoidosis, the exact cause of scleroderma is unknown, but it involves an overproduction of collagen and may be linked to an abnormal immune response. While inflammation is a component of scleroderma, and fibrinogen is an acute-phase protein that might be elevated in response to inflammation, there is no direct evidence to suggest that high fibrinogen levels cause scleroderma.

Considerations

In both sarcoidosis and scleroderma, inflammation is a key feature, and high fibrinogen levels could be a secondary effect rather than a causative factor. Elevated fibrinogen levels indicate an increased inflammatory state or acute-phase response, which could occur in a wide range of diseases, including autoimmune and inflammatory conditions. Thus, while high fibrinogen levels might be observed in these conditions, they are not directly linked to causing them. Research into the exact causes and mechanisms of diseases like sarcoidosis and scleroderma continues, with a focus on genetic, environmental, and immunological factors.

 

Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more